Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Laboratories Gets CE Mark for SARS-CoV-2 Kit

NEW YORK – Bio-Rad Laboratories announced on Tuesday that it has received CE-IVD mark for a kit to detect SARS-CoV-2. The test kit is now launched in European markets.

The Reliance SARS-CoV-2 RT-PCR Kit is a real-time reverse-transcriptase PCR test that detects the N1 and N2 regions of the nucleocapsid gene from nasopharyngeal swab samples. The kit contains the firm's controls as well as assay reagents and is validated on Bio-Rad's CFX96 Dx RT-PCR system as well as other RT-PCR systems.

"The assay kit is the latest addition to our COVID-19 offering of research and testing products, reflecting our ongoing commitment to helping in the fight against COVID-19," said Steven Blakely, Bio-Rad's global director of marketing for the gene expression division of the life science group.

The Reliance SARS-CoV-2 RT-PCR Kit was previously granted Emergency Use Authorization by the US Food and Drug Administration in January.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.